Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation
Episode Summary
Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.